Dei Policy Shifts Under Trump Administration Sparks Industry-Wide Changes
Pfizer has made significant changes to its diversity, equity, and inclusion (DEI) webpage, aligning itself closer to the Trump administration's efforts to eliminate DEI programs across public and private sectors. The company pulled language relating to diversity initiatives from its DEI page and emphasized "merit" in its new approach. Pfizer's changes reflect a broader industry trend as major American corporations adjust their public approaches to DEI.
- The shift towards merit-based DEI policies may mask the erosion of existing programs, potentially exacerbating inequality in the pharmaceutical industry.
- How will the normalization of DEI policy under the Trump administration impact marginalized communities and access to essential healthcare services?